Helix Immuno-Oncology

Business Data, Corporate Office and Headquarter Address

About

Helix Immuno-Oncology is Drug Discovery in Poland that focus on operator business. Founded in 2013. They cover business area such as operator, cancer immunotherapy product, proprietary technology, Warsaw, Poland, anti-cancer immunotherapy, tumor defense technology, triple-negative breast cancer.

Business Type

Drug Discovery

Country

Poland

Founded

2013
( 11 years old in 2024 )

Company Focus

Operator

Website

-

Corporate Office and Headquarter Office address:

Gen. Sylwestra Kaliski 2
Warsaw, 01-476
Poland

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

operatorcancer immunotherapy productproprietary technologyWarsawPolandanti-cancer immunotherapytumor defense technologytriple-negative breast cancer

* We use standard office opening hours in near Helix Immuno-Oncology's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Helix Immuno-Oncology Frequently Asked Questions

What or who is Helix Immuno-Oncology?

Helix Immuno-Oncology is Drug Discovery business from Poland that founded in 2013 (11 years old in 2024), Helix Immuno-Oncology business is focusing on Operator.

Where is Helix Immuno-Oncology headquarter and corporate office address?

Helix Immuno-Oncology headquarter office and corporate office address is located in Gen. Sylwestra Kaliski 2 Warsaw, 01-476 Poland.

Where is Helix Immuno-Oncology country origins?

Helix Immuno-Oncology was founded in Poland.

What is Operator business focus on?

In 2024, Helix Immuno-Oncology is currently focus on operator sector.

Operator Business Interest from Google Trend

Above is snippet of Google Trends for "operator" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with Helix Immuno-Oncology, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.